Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)
Clinical trial NCT01414166 · TERMINATED
Trial details
- NCT number
- NCT01414166
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-02-01
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.